Gray baby syndrome is an adverse reaction to chloramphenicol that is characterized by abdominal distention, hemodynamic collapse, and ashen-gray skin discoloration in neonates. This activity reviews the evaluation and treatment of gray baby syndrome and explains the role of the interprofessional team in reducing morbidity and improving care for affected patients.

**Objectives:**
- Identify the etiology of gray baby syndrome.
- Describe the evaluation of gray baby syndrome.
- Outline the management options available for gray baby syndrome.
- Summarize interprofessional team strategies for improving care coordination and communication to advance management for gray baby syndrome and improve outcomes.